Logo image of BG

BUNGE GLOBAL SA (BG) Stock Fundamental Analysis

NYSE:BG - New York Stock Exchange, Inc. - CH1300646267 - Common Stock - Currency: USD

74.03  +0.45 (+0.61%)

Fundamental Rating

5

Taking everything into account, BG scores 5 out of 10 in our fundamental rating. BG was compared to 90 industry peers in the Food Products industry. BG has only an average score on both its financial health and profitability. BG has a valuation in line with the averages, but it does not seem to be growing. Finally BG also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BG had positive earnings in the past year.
BG had a positive operating cash flow in the past year.
In the past 5 years BG has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: BG reported negative operating cash flow in multiple years.
BG Yearly Net Income VS EBIT VS OCF VS FCFBG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B -6B

1.2 Ratios

BG has a better Return On Assets (4.57%) than 60.71% of its industry peers.
Looking at the Return On Equity, with a value of 10.39%, BG is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
The Return On Invested Capital of BG (7.56%) is better than 72.62% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BG is in line with the industry average of 9.13%.
Industry RankSector Rank
ROA 4.57%
ROE 10.39%
ROIC 7.56%
ROA(3y)6.65%
ROA(5y)6.66%
ROE(3y)16.17%
ROE(5y)18.73%
ROIC(3y)10.77%
ROIC(5y)10.22%
BG Yearly ROA, ROE, ROICBG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

BG has a Profit Margin of 2.14%. This is comparable to the rest of the industry: BG outperforms 44.05% of its industry peers.
BG's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 3.39%, BG perfoms like the industry average, outperforming 46.43% of the companies in the same industry.
In the last couple of years the Operating Margin of BG has grown nicely.
BG has a Gross Margin of 6.39%. This is in the lower half of the industry: BG underperforms 79.76% of its industry peers.
BG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.39%
PM (TTM) 2.14%
GM 6.39%
OM growth 3Y-7.82%
OM growth 5Y6.69%
PM growth 3Y-14.75%
PM growth 5YN/A
GM growth 3Y2.27%
GM growth 5Y3.43%
BG Yearly Profit, Operating, Gross MarginsBG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BG is still creating some value.
Compared to 1 year ago, BG has less shares outstanding
BG has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, BG has a worse debt to assets ratio.
BG Yearly Shares OutstandingBG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
BG Yearly Total Debt VS Total AssetsBG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

BG has a debt to FCF ratio of 11.90. This is a negative value and a sign of low solvency as BG would need 11.90 years to pay back of all of its debts.
BG has a Debt to FCF ratio (11.90) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.51 indicates that BG is somewhat dependend on debt financing.
BG has a Debt to Equity ratio (0.51) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 11.9
Altman-Z N/A
ROIC/WACC1.05
WACC7.18%
BG Yearly LT Debt VS Equity VS FCFBG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B

2.3 Liquidity

A Current Ratio of 2.15 indicates that BG has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.15, BG is doing good in the industry, outperforming 64.29% of the companies in the same industry.
BG has a Quick Ratio of 1.27. This is a normal value and indicates that BG is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.27, BG is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 1.27
BG Yearly Current Assets VS Current LiabilitesBG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

3

3. Growth

3.1 Past

The earnings per share for BG have decreased strongly by -32.77% in the last year.
Measured over the past years, BG shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.28% on average per year.
The Revenue for BG has decreased by -10.80% in the past year. This is quite bad
BG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.24% yearly.
EPS 1Y (TTM)-32.77%
EPS 3Y-10.8%
EPS 5Y20.28%
EPS Q2Q%-42.43%
Revenue 1Y (TTM)-10.8%
Revenue growth 3Y-3.53%
Revenue growth 5Y5.24%
Sales Q2Q%-9.33%

3.2 Future

BG is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.47% yearly.
BG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.07% yearly.
EPS Next Y-12.05%
EPS Next 2Y-1.24%
EPS Next 3Y0.47%
EPS Next 5YN/A
Revenue Next Year1.67%
Revenue Next 2Y1.75%
Revenue Next 3Y2.07%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BG Yearly Revenue VS EstimatesBG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B
BG Yearly EPS VS EstimatesBG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.06, the valuation of BG can be described as reasonable.
Based on the Price/Earnings ratio, BG is valued cheaper than 92.86% of the companies in the same industry.
BG is valuated cheaply when we compare the Price/Earnings ratio to 29.53, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 9.16, which indicates a very decent valuation of BG.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BG indicates a rather cheap valuation: BG is cheaper than 96.43% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.65. BG is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.06
Fwd PE 9.16
BG Price Earnings VS Forward Price EarningsBG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BG indicates a rather cheap valuation: BG is cheaper than 86.90% of the companies listed in the same industry.
BG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BG is cheaper than 63.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.86
EV/EBITDA 5.23
BG Per share dataBG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.4
EPS Next 2Y-1.24%
EPS Next 3Y0.47%

7

5. Dividend

5.1 Amount

BG has a Yearly Dividend Yield of 3.82%.
BG's Dividend Yield is a higher than the industry average which is at 3.93.
BG's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 3.82%

5.2 History

The dividend of BG has a limited annual growth rate of 3.89%.
BG has been paying a dividend for at least 10 years, so it has a reliable track record.
BG has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.89%
Div Incr Years4
Div Non Decr Years23
BG Yearly Dividends per shareBG Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

BG pays out 33.25% of its income as dividend. This is a sustainable payout ratio.
The dividend of BG is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP33.25%
EPS Next 2Y-1.24%
EPS Next 3Y0.47%
BG Yearly Income VS Free CF VS DividendBG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B -6B
BG Dividend Payout.BG Dividend Payout, showing the Payout Ratio.BG Dividend Payout.PayoutRetained Earnings

BUNGE GLOBAL SA

NYSE:BG (2/25/2025, 12:35:09 PM)

74.03

+0.45 (+0.61%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-05 2025-02-05/bmo
Earnings (Next)04-22 2025-04-22/bmo
Inst Owners90.97%
Inst Owner Change-92.83%
Ins Owners0.98%
Ins Owner Change0.11%
Market Cap9.88B
Analysts78
Price Target94.06 (27.06%)
Short Float %2.79%
Short Ratio2.2
Dividend
Industry RankSector Rank
Dividend Yield 3.82%
Yearly Dividend2.71
Dividend Growth(5Y)3.89%
DP33.25%
Div Incr Years4
Div Non Decr Years23
Ex-Date02-18 2025-02-18 (0.68)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.17%
Min EPS beat(2)-7.78%
Max EPS beat(2)3.43%
EPS beat(4)2
Avg EPS beat(4)1.45%
Min EPS beat(4)-7.78%
Max EPS beat(4)16.61%
EPS beat(8)5
Avg EPS beat(8)10.25%
EPS beat(12)7
Avg EPS beat(12)11.93%
EPS beat(16)11
Avg EPS beat(16)29.39%
Revenue beat(2)0
Avg Revenue beat(2)-2.63%
Min Revenue beat(2)-3.35%
Max Revenue beat(2)-1.9%
Revenue beat(4)0
Avg Revenue beat(4)-5.46%
Min Revenue beat(4)-9.94%
Max Revenue beat(4)-1.9%
Revenue beat(8)1
Avg Revenue beat(8)-5.7%
Revenue beat(12)3
Avg Revenue beat(12)-4.77%
Revenue beat(16)6
Avg Revenue beat(16)-0.02%
PT rev (1m)-13.52%
PT rev (3m)-17.27%
EPS NQ rev (1m)-40.5%
EPS NQ rev (3m)-49.55%
EPS NY rev (1m)-14.6%
EPS NY rev (3m)-15.64%
Revenue NQ rev (1m)2.05%
Revenue NQ rev (3m)-9.32%
Revenue NY rev (1m)-4.25%
Revenue NY rev (3m)2.4%
Valuation
Industry RankSector Rank
PE 8.06
Fwd PE 9.16
P/S 0.19
P/FCF 18.86
P/OCF 5.2
P/B 0.9
P/tB 0.97
EV/EBITDA 5.23
EPS(TTM)9.19
EY12.41%
EPS(NY)8.08
Fwd EY10.92%
FCF(TTM)3.93
FCFY5.3%
OCF(TTM)14.23
OCFY19.23%
SpS397.87
BVpS82
TBVpS76.2
PEG (NY)N/A
PEG (5Y)0.4
Profitability
Industry RankSector Rank
ROA 4.57%
ROE 10.39%
ROCE 10.32%
ROIC 7.56%
ROICexc 9.23%
ROICexgc 9.73%
OM 3.39%
PM (TTM) 2.14%
GM 6.39%
FCFM 0.99%
ROA(3y)6.65%
ROA(5y)6.66%
ROE(3y)16.17%
ROE(5y)18.73%
ROIC(3y)10.77%
ROIC(5y)10.22%
ROICexc(3y)12.86%
ROICexc(5y)11.97%
ROICexgc(3y)13.65%
ROICexgc(5y)12.78%
ROCE(3y)14.6%
ROCE(5y)14.18%
ROICexcg growth 3Y-15.42%
ROICexcg growth 5Y5.22%
ROICexc growth 3Y-14.88%
ROICexc growth 5Y6.42%
OM growth 3Y-7.82%
OM growth 5Y6.69%
PM growth 3Y-14.75%
PM growth 5YN/A
GM growth 3Y2.27%
GM growth 5Y3.43%
F-Score5
Asset Turnover2.13
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 11.9
Debt/EBITDA 2.45
Cap/Depr 294.02%
Cap/Sales 2.59%
Interest Coverage 250
Cash Conversion 83.7%
Profit Quality 46.09%
Current Ratio 2.15
Quick Ratio 1.27
Altman-Z N/A
F-Score5
WACC7.18%
ROIC/WACC1.05
Cap/Depr(3y)226.28%
Cap/Depr(5y)171.37%
Cap/Sales(3y)1.77%
Cap/Sales(5y)1.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.77%
EPS 3Y-10.8%
EPS 5Y20.28%
EPS Q2Q%-42.43%
EPS Next Y-12.05%
EPS Next 2Y-1.24%
EPS Next 3Y0.47%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.8%
Revenue growth 3Y-3.53%
Revenue growth 5Y5.24%
Sales Q2Q%-9.33%
Revenue Next Year1.67%
Revenue Next 2Y1.75%
Revenue Next 3Y2.07%
Revenue Next 5YN/A
EBIT growth 1Y-44.59%
EBIT growth 3Y-11.07%
EBIT growth 5Y12.28%
EBIT Next Year28.75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-76.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-42.56%
OCF growth 3YN/A
OCF growth 5YN/A